Supernus Pharmaceuticals's total assets for Q3 2025 were $1.42T, an increase of 102601.74% from the previous quarter. CH:S49 total liabilities were $370.09B for the fiscal quarter, a 116095.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.